MINERVA NEUROSCIENCES INC Logo
US6033802058

MINERVA NEUROSCIENCES INC

Ins Portfolio
Kostengünstig und breit gestreut in Europa investieren. Jetzt entdecken
Anzeige

Kurse werden geladen...

Prognose

Das durchschnittliche Kursziel der Analysten beträgt +13,64(+874,29%). Der Median liegt bei +13,64(+874,29%).

Kaufen
  6
Halten
  10
Verkaufen
  1

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News


  • Gold Fields: Positioned To Shine In The Coming Gold Bull Market

    Gold Fields is well-positioned to benefit from the ongoing gold bull run, supported by macroeconomic uncertainty and de-dollarization trends. Aggressive capex spending and geographical diversification reduce risk and set the stage for future production growth and profitability. The Windfall project in Canada offers low operating costs and a decade of high-margin production, enhancing Gold Fields' competitive edge.» Mehr auf seekingalpha.com


  • Beauce Gold Fields Launches Drill Campaign Along the Antiform Saddle Reef Structure

    July 2, 2025 – TheNewswire – Montreal, Quebec - Beauce Gold Fields (Champs D'Or en Beauce) (TSX Venture: "BGF"), referred to as "BGF" or the "Company," is pleased to announce the launch of a drilling campaign targeting high-priority zones along the antiform Saddle Reef structure. This structure has been identified as a likely source of historical placer gold deposits on the Beauce Gold property, located in southern Quebec.   Patrick Levasseur, President and CEO of Beauce Gold Fields, stated: “We are excited to commence drilling on promising targets along the structure believed to be the source of the region's historical placer gold deposits.  We sincerely thank the property owners who have graciously granted us access to their land and, in doing so, have joined us as valued stakeholders in the potential for future gold discoveries.”» Mehr auf thenewswire.com


  • The 5 Best ETFs to Cash in on Soaring Gold Prices

    This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Safe-haven investors are still jumping into gold despite the precious metal’s recent pullback. But macro conditions remain primed for gold to continue its incredible run. For one, the U.S. dollar is still showing signs of weakness, down roughly 10% over the past six months. Second, there’s still plenty of geopolitical and economic uncertainty, with the ongoing trade war as well as the war between Ukraine and Russia and Israel and Iran. Third, central banks are still buying, on track to buy 1,000 metric tons of gold this year. So for gold bugs looking to get exposure through equities, 24/7 Wall St. conducted research to find five gold exchange-traded funds (ETFs) that are worth of your consideration. Key Points in This Article: Analysts believe the price of gold could reach $4,000 per troy ounce by the middle of 2026. These gold ETFs allow you get a piece of the rally without owning the physical metal. Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; get started by clicking here. (Sponsor) Gold’s Outlook China’s central bank, for example, added to its reserves for the seventh straight month, rising to 73.83 million fine troy ounces at the end of May from 73.77 million in April. Plus, Goldman Sachs says gold could rally to $3,700 by the end of 2025, and to $4,000 by the middle of 2026. Even UBS analysts say gold could rally to $3,500 by December. According to analysts at JPMorgan, “The bank now expects gold prices to reach an average of $3,675/oz by 4Q25, on the way towards above $4,000/oz by 2Q26, with risks skewed towards an earlier overshoot of these forecasts if demand surpasses its expectations,” as reported by Reuters. One of the best ways to cash in on those soaring gold prices is with these ETFs. Not only do they allow you to diversify, but they also allow you to do it with less capital. Here are five you may want to dig into. VanEck Vectors Gold Miners ETF One of the best ways to diversify at less cost is with an ETF, such as the VanEck Vectors Gold Miners ETF (NYSEARCA: GDX). Not only can you gain access to some of the biggest gold stocks in the world, but you can do so at less cost. With an expense ratio of 0.51%, the ETF holds positions in Newmont Corp., Barrick Gold, Franco-Nevada, Agnico Eagle Mines, Gold Fields, and Wheaton Precious Metals, to name a few. We should also note that shares of mining stocks often outperform the price of gold. That’s because higher gold prices can result in increased profit margins and free cash flow for gold miners. In addition, top gold miners often have limited exposure to riskier mining projects. Last trading at $51.92, we’d like to see the GDX ETF rally to $60 initially. Sprott Junior Gold Miners ETF With an expense ratio of 0.5%, the Sprott Junior Gold Miners ETF (NYSEARCA: SGDJ) seeks investment results that correspond to the performance of its underlying index, the Solactive Junior Gold Miners Custom Factors Index. Some of its top holdings include Lundin Gold Inc., Seabridge Gold, Equinox Gold, Victoria Gold, Westgold Resources, Osisko Mining, K92 Mining Inc., Novagold Resources, Regis Resources, New Gold Inc., Sabina Gold & Silver, Argonaut Gold, Centerra Gold, Coeur Mining, Skeena Resources, and K92 Mining to name a few. From its last traded price of $48.93, we’d like to see the SGDJ ETF initially test $55. Global X Gold Explorers ETF With an expense ratio of 0.65%, the Global X Explorers ETF (NYSEARCA: GOEX) offers exposure to companies involved in the exploration of gold deposits. Some of its 51 holdings include Coeur Mining, Lundin Gold, Equinox Gold, Eldorado Gold, New Gold, Hecla Mining, and Alamos Gold, to name a few. Even after rallying from a 2025 low of about $29.94 to $45.06, there’s still plenty of upside opportunity in the GOEX ETF. From $45.06, we’d like to see the ETF initially test $52 a share. VanEck Merk Gold ETF With an expense ratio of 0.25%, the VanEck Merk Gold ETF (NYSEARCA: OUNZ) “holds gold bullion in the form of allocated London Bars. It differentiates itself by providing investors with the option to take physical delivery of gold bullion in exchange for their shares,” as noted by VanEck.com. Since its 2025 low of about $25, the OUNZ ETF rallied to a recent high of $32.12. From here, we’d like to see it initially test $40 a share, which is doable with gold’s unstoppable rally. iShares MSCI Global Gold Miners ETF There’s also the iShares MSCI Global Gold Miners ETF (NASDAQ: RING). With an expense ratio of 0.39%, the RING ETF offers exposure to global companies involved in gold mining. Some of its 41 holdings include Newmont, Agnico Eagle Mines, Wheaton Precious Metals, Barrick Mining, Gold Fields, and Kinross Gold, to name just a few. From its 2025 low of about $28, the iShares MSCI Global Gold Miners ETF rallied to a recent high of $43.54. From here, we’d like to see the ETF initially test $50 a share. Even better, as we wait for the RING ETF to appreciate, we can also collect its dividends. On June 20, it paid out a dividend of $0.23. On December 20, it paid $0.21. The post The 5 Best ETFs to Cash in on Soaring Gold Prices appeared first on 24/7 Wall St..» Mehr auf 247wallst.com

Dividenden

Alle Kennzahlen
In 2023 hat MINERVA NEUROSCIENCES INC +0,23 Dividende ausgeschüttet. Die letzte Dividende wurde im Januar 2023 gezahlt.

Unternehmenszahlen

Im letzten Quartal hatte MINERVA NEUROSCIENCES INC einen Umsatz von +2,96 Mrd und ein Nettoeinkommen von +822,63 Mio
(EUR)Dez. 2024
YOY
Umsatz+2,96 Mrd-
Bruttoeinkommen+1,78 Mrd-
Nettoeinkommen+822,63 Mio-
EBITDA+1,67 Mrd-

Fundamentaldaten

MetrikWert
Marktkapitalisierung
+18,46 Mrd
Anzahl Aktien
895,02 Mio
52 Wochen-Hoch/Tief
+22,47 - +11,06
DividendenNein
Beta
0,5
KGV (PE Ratio)
+56,65
KGWV (PEG Ratio)
+3,82
KBV (PB Ratio)
+4,24
KUV (PS Ratio)
+10,30

Unternehmensprofil

Minerva Neurosciences, Inc. ist ein biopharmazeutisches Unternehmen im klinischen Stadium, das sich auf die Entwicklung und Vermarktung von Produktkandidaten für die Behandlung von Krankheiten des zentralen Nervensystems konzentriert. Der führende Produktkandidat ist Roluperidon für die Behandlung von Schizophrenie und MIN-301, eine lösliche rekombinante Form des Proteins Neuregulin-1b1 für die Behandlung der Parkinson-Krankheit und anderer neurodegenerativer Erkrankungen. Minerva Neurosciences, Inc. hat eine Lizenzvereinbarung mit der Mitsubishi Tanabe Pharma Corporation für die Entwicklung, den Verkauf und den Import von Roluperidon weltweit mit Ausnahme Asiens. Das Unternehmen war früher als Cyrenaic Pharmaceuticals, Inc. bekannt und änderte 2013 seinen Namen in Minerva Neurosciences, Inc. Minerva Neurosciences, Inc. wurde im Jahr 2007 gegründet und hat seinen Hauptsitz in Waltham, Massachusetts.

Name
MINERVA NEUROSCIENCES INC
CEO
Michael John Fraser MBL
SitzSandton,
USA
Website
Industrie
Chemikalien
Börsengang
Mitarbeiter6.560

Ticker Symbole

BörseSymbol
NASDAQ
NERV
Frankfurt
4MNA.F
München
4MNA.MU
Japan Exchange Group
4014.T
NYSE
GFI
Pnk
CYRBY
London Stock Exchange
WCW.L
Düsseldorf
4MNA.DU
🍪

Parqet nutzt Cookies.Erfahre Mehr